Providence Clears 3D Printed Cervical Spine Implant
Providence Medical Technology's CORUS PCSS 3D-T, a porous titanium spinal implant, has received FDA 510(k) clearance and its first commercial procedures are underway.
Updated on Nov. 10, 2026 in Healthcare

Providence Medical Technology received FDA 510(k) clearance for the CORUS PCSS 3D-T, a 3D printed porous titanium version of its CORUS Posterior Cervical Stabilization System. Surgeons in California and Virginia have completed the first commercial procedures with the device.
Why it matters
The device is indicated to stabilize spinal segments as a supplement to posterior cervical fusion in patients with cervical degenerative disc disease, a common cause of neck pain and nerve compression. Its clearance adds an additive-manufactured option to a surgical market for spinal fixation hardware.
The implant's porous titanium lattice gives it 1.5 times the surface area and eight times the surface roughness of the original machined CORUS PCSS, which is the basis for the design claims. Providence has not yet published clinical outcome data for the 3D printed version.
The players
Providence Medical Technology
Providence Medical Technology is a medical device company that develops spinal implant systems, including the CORUS line of posterior cervical stabilization hardware.
The details
The CORUS PCSS 3D-T retains the core design of the earlier CORUS PCSS and adds a proprietary titanium lattice modeled on cancellous bone, with room to pack graft inside. It is placed on both sides of the spine through a posterior surgical approach.
Timeline
May 2025: Interim results of the earlier CORUS PCSS trial were published in Spine.
October 29: First commercial procedures with the device were announced.
Under the Hood
The CORUS PCSS 3D-T extends the original machined CORUS Posterior Cervical Stabilization System by replacing its solid surface with an additively manufactured porous titanium lattice. The earlier device's randomized trial, NCT04229017, is the clinical baseline against which the new design's outcomes will eventually be judged.
Patients with cervical degenerative disc disease may encounter this 3D printed implant as a surgical option once hospitals adopt it. Its clinical benefit relative to the machined version has not yet been demonstrated in published data.
The takeaway
Additive manufacturing is expanding the design options for spinal implants, but surgeons and patients will rely on clinical outcome data to judge whether porous surfaces improve fusion. Readers researching cervical fusion should ask their surgeons which evidence supports a given implant.
Further reading
Explore more Healthcare coverage for context on device approvals and surgical technology.
Source note: This article includes information reported by 3D Printing Industry.






